News for Healthier Living
Lipid droplet gene signatures classify liver cancer and identify PLIN3 as a therapeutic target
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and remains one of the leading causes of cancer-related deaths worldwide. Despite advances in targeted therapies and immunotherapy, substantial molecular heterogeneity continues to limit accurate prognostic prediction and effective treatment selection. While metabolic reprogramming is increasingly recognized as a hallmark of HCC, the contribution of lipid droplet-associated genes (LDAGs) to tumor classification and disease progression has remained poorly defined.
August 18, 2026
August 30 2026August 29 2026August 28 2026August 27 2026August 26 2026August 25 2026August 24 2026August 21 2026August 20 2026August 19 2026August 18 2026August 17 2026August 16 2026
|
|
|
|
|